nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Paclitaxel—ovarian cancer	0.127	0.253	CbGbCtD
Argatroban—CYP3A4—Topotecan—ovarian cancer	0.0999	0.2	CbGbCtD
Argatroban—CYP3A5—Docetaxel—ovarian cancer	0.0917	0.183	CbGbCtD
Argatroban—CYP3A4—Vinorelbine—ovarian cancer	0.0704	0.141	CbGbCtD
Argatroban—CYP3A4—Paclitaxel—ovarian cancer	0.0494	0.0988	CbGbCtD
Argatroban—F2—vein—ovarian cancer	0.0388	0.601	CbGeAlD
Argatroban—CYP3A4—Docetaxel—ovarian cancer	0.0357	0.0714	CbGbCtD
Argatroban—CYP3A4—Doxorubicin—ovarian cancer	0.0266	0.0532	CbGbCtD
Argatroban—F2—epithelium—ovarian cancer	0.006	0.0929	CbGeAlD
Argatroban—F2—IL1 and megakaryotyces in obesity—SELENBP1—ovarian cancer	0.00521	0.127	CbGpPWpGaD
Argatroban—F2—female reproductive system—ovarian cancer	0.00445	0.069	CbGeAlD
Argatroban—F2—bone marrow—ovarian cancer	0.0042	0.0651	CbGeAlD
Argatroban—F2—female gonad—ovarian cancer	0.00405	0.0628	CbGeAlD
Argatroban—F2—Folate Metabolism—FOLR1—ovarian cancer	0.00306	0.0749	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—RRAS2—ovarian cancer	0.00248	0.0606	CbGpPWpGaD
Argatroban—CYP3A5—uterine cervix—ovarian cancer	0.00241	0.0373	CbGeAlD
Argatroban—Thrombosis—Epirubicin—ovarian cancer	0.00166	0.0042	CcSEcCtD
Argatroban—CYP3A5—female gonad—ovarian cancer	0.00164	0.0254	CbGeAlD
Argatroban—CYP3A5—vagina—ovarian cancer	0.00163	0.0253	CbGeAlD
Argatroban—Angiopathy—Topotecan—ovarian cancer	0.00162	0.00412	CcSEcCtD
Argatroban—Renal failure acute—Paclitaxel—ovarian cancer	0.00161	0.00409	CcSEcCtD
Argatroban—Haemoptysis—Epirubicin—ovarian cancer	0.00158	0.00402	CcSEcCtD
Argatroban—Atrial fibrillation—Paclitaxel—ovarian cancer	0.00157	0.00398	CcSEcCtD
Argatroban—Renal impairment—Paclitaxel—ovarian cancer	0.00156	0.00397	CcSEcCtD
Argatroban—Haematemesis—Doxorubicin—ovarian cancer	0.00156	0.00396	CcSEcCtD
Argatroban—Pulmonary oedema—Docetaxel—ovarian cancer	0.00155	0.00392	CcSEcCtD
Argatroban—Thrombosis—Doxorubicin—ovarian cancer	0.00153	0.00389	CcSEcCtD
Argatroban—Pleural effusion—Epirubicin—ovarian cancer	0.00153	0.00388	CcSEcCtD
Argatroban—Cardiac failure—Paclitaxel—ovarian cancer	0.00152	0.00387	CcSEcCtD
Argatroban—Cerebrovascular accident—Paclitaxel—ovarian cancer	0.00152	0.00385	CcSEcCtD
Argatroban—Sepsis—Docetaxel—ovarian cancer	0.00151	0.00382	CcSEcCtD
Argatroban—Back pain—Topotecan—ovarian cancer	0.00151	0.00382	CcSEcCtD
Argatroban—Haemoptysis—Doxorubicin—ovarian cancer	0.00146	0.00372	CcSEcCtD
Argatroban—Thrombophlebitis—Docetaxel—ovarian cancer	0.00146	0.0037	CcSEcCtD
Argatroban—Confusional state—Chlorambucil—ovarian cancer	0.00144	0.00365	CcSEcCtD
Argatroban—Infection—Chlorambucil—ovarian cancer	0.00142	0.0036	CcSEcCtD
Argatroban—Pleural effusion—Doxorubicin—ovarian cancer	0.00142	0.00359	CcSEcCtD
Argatroban—Cardiac arrest—Paclitaxel—ovarian cancer	0.00141	0.00359	CcSEcCtD
Argatroban—Angiopathy—Vinorelbine—ovarian cancer	0.00139	0.00352	CcSEcCtD
Argatroban—Cough—Topotecan—ovarian cancer	0.00136	0.00345	CcSEcCtD
Argatroban—CYP3A4—female reproductive system—ovarian cancer	0.00135	0.021	CbGeAlD
Argatroban—Vasodilation procedure—Epirubicin—ovarian cancer	0.00133	0.00338	CcSEcCtD
Argatroban—Vasodilation—Epirubicin—ovarian cancer	0.00133	0.00338	CcSEcCtD
Argatroban—Atrial fibrillation—Docetaxel—ovarian cancer	0.00133	0.00338	CcSEcCtD
Argatroban—Cough—Melphalan—ovarian cancer	0.00133	0.00338	CcSEcCtD
Argatroban—Chest pain—Topotecan—ovarian cancer	0.00133	0.00336	CcSEcCtD
Argatroban—Renal impairment—Docetaxel—ovarian cancer	0.00132	0.00336	CcSEcCtD
Argatroban—Dermatitis bullous—Docetaxel—ovarian cancer	0.00132	0.00335	CcSEcCtD
Argatroban—Chest pain—Melphalan—ovarian cancer	0.0013	0.00329	CcSEcCtD
Argatroban—Cardiac failure—Docetaxel—ovarian cancer	0.00129	0.00328	CcSEcCtD
Argatroban—Back pain—Vinorelbine—ovarian cancer	0.00129	0.00327	CcSEcCtD
Argatroban—Infection—Topotecan—ovarian cancer	0.00126	0.0032	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00126	0.0032	CcSEcCtD
Argatroban—Dyspepsia—Chlorambucil—ovarian cancer	0.00126	0.00319	CcSEcCtD
Argatroban—Infection—Melphalan—ovarian cancer	0.00124	0.00314	CcSEcCtD
Argatroban—Vasodilation procedure—Doxorubicin—ovarian cancer	0.00123	0.00313	CcSEcCtD
Argatroban—Vasodilation—Doxorubicin—ovarian cancer	0.00123	0.00313	CcSEcCtD
Argatroban—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00123	0.00313	CcSEcCtD
Argatroban—Pain—Chlorambucil—ovarian cancer	0.00122	0.0031	CcSEcCtD
Argatroban—Tachycardia—Melphalan—ovarian cancer	0.00121	0.00308	CcSEcCtD
Argatroban—Feeling abnormal—Chlorambucil—ovarian cancer	0.00118	0.00298	CcSEcCtD
Argatroban—Pulmonary embolism—Epirubicin—ovarian cancer	0.00117	0.00297	CcSEcCtD
Argatroban—Ventricular tachycardia—Epirubicin—ovarian cancer	0.00117	0.00297	CcSEcCtD
Argatroban—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00117	0.00296	CcSEcCtD
Argatroban—Hypotension—Melphalan—ovarian cancer	0.00116	0.00295	CcSEcCtD
Argatroban—Cough—Vinorelbine—ovarian cancer	0.00116	0.00295	CcSEcCtD
Argatroban—Pneumonia—Paclitaxel—ovarian cancer	0.00115	0.00293	CcSEcCtD
Argatroban—Chest pain—Vinorelbine—ovarian cancer	0.00113	0.00288	CcSEcCtD
Argatroban—Dyspnoea—Topotecan—ovarian cancer	0.00113	0.00287	CcSEcCtD
Argatroban—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00113	0.00287	CcSEcCtD
Argatroban—Body temperature increased—Chlorambucil—ovarian cancer	0.00113	0.00286	CcSEcCtD
Argatroban—Abdominal pain—Chlorambucil—ovarian cancer	0.00113	0.00286	CcSEcCtD
Argatroban—Myocardial infarction—Paclitaxel—ovarian cancer	0.00112	0.00285	CcSEcCtD
Argatroban—Dyspepsia—Topotecan—ovarian cancer	0.00112	0.00284	CcSEcCtD
Argatroban—Urinary tract infection—Paclitaxel—ovarian cancer	0.00111	0.00283	CcSEcCtD
Argatroban—Dyspnoea—Melphalan—ovarian cancer	0.00111	0.00281	CcSEcCtD
Argatroban—Gastrointestinal disorder—Topotecan—ovarian cancer	0.0011	0.00278	CcSEcCtD
Argatroban—Dyspepsia—Melphalan—ovarian cancer	0.0011	0.00278	CcSEcCtD
Argatroban—Haematuria—Paclitaxel—ovarian cancer	0.00109	0.00277	CcSEcCtD
Argatroban—Pain—Topotecan—ovarian cancer	0.00109	0.00276	CcSEcCtD
Argatroban—Constipation—Topotecan—ovarian cancer	0.00109	0.00276	CcSEcCtD
Argatroban—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00108	0.00275	CcSEcCtD
Argatroban—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00108	0.00275	CcSEcCtD
Argatroban—Infection—Vinorelbine—ovarian cancer	0.00108	0.00274	CcSEcCtD
Argatroban—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00107	0.00273	CcSEcCtD
Argatroban—Pain—Melphalan—ovarian cancer	0.00106	0.0027	CcSEcCtD
Argatroban—Angina pectoris—Docetaxel—ovarian cancer	0.00106	0.00269	CcSEcCtD
Argatroban—Tachycardia—Vinorelbine—ovarian cancer	0.00106	0.00269	CcSEcCtD
Argatroban—Hypersensitivity—Chlorambucil—ovarian cancer	0.00105	0.00267	CcSEcCtD
Argatroban—Bradycardia—Paclitaxel—ovarian cancer	0.00105	0.00266	CcSEcCtD
Argatroban—Feeling abnormal—Topotecan—ovarian cancer	0.00105	0.00266	CcSEcCtD
Argatroban—Pulmonary oedema—Epirubicin—ovarian cancer	0.00104	0.00265	CcSEcCtD
Argatroban—Gastrointestinal pain—Topotecan—ovarian cancer	0.00104	0.00264	CcSEcCtD
Argatroban—Haemoglobin—Paclitaxel—ovarian cancer	0.00103	0.00262	CcSEcCtD
Argatroban—Haemorrhage—Paclitaxel—ovarian cancer	0.00103	0.00261	CcSEcCtD
Argatroban—Sepsis—Epirubicin—ovarian cancer	0.00102	0.00258	CcSEcCtD
Argatroban—Hypotension—Vinorelbine—ovarian cancer	0.00102	0.00258	CcSEcCtD
Argatroban—Abdominal pain—Topotecan—ovarian cancer	0.001	0.00255	CcSEcCtD
Argatroban—Body temperature increased—Topotecan—ovarian cancer	0.001	0.00255	CcSEcCtD
Argatroban—Thrombophlebitis—Epirubicin—ovarian cancer	0.000982	0.00249	CcSEcCtD
Argatroban—Pneumonia—Docetaxel—ovarian cancer	0.000977	0.00248	CcSEcCtD
Argatroban—Diarrhoea—Chlorambucil—ovarian cancer	0.000977	0.00248	CcSEcCtD
Argatroban—Dyspnoea—Vinorelbine—ovarian cancer	0.000969	0.00246	CcSEcCtD
Argatroban—Pulmonary oedema—Doxorubicin—ovarian cancer	0.000965	0.00245	CcSEcCtD
Argatroban—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000958	0.00243	CcSEcCtD
Argatroban—Myocardial infarction—Docetaxel—ovarian cancer	0.000952	0.00242	CcSEcCtD
Argatroban—Sepsis—Doxorubicin—ovarian cancer	0.000941	0.00239	CcSEcCtD
Argatroban—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000938	0.00238	CcSEcCtD
Argatroban—Hypersensitivity—Topotecan—ovarian cancer	0.000936	0.00238	CcSEcCtD
Argatroban—Angiopathy—Paclitaxel—ovarian cancer	0.000934	0.00237	CcSEcCtD
Argatroban—Constipation—Vinorelbine—ovarian cancer	0.00093	0.00236	CcSEcCtD
Argatroban—Pain—Vinorelbine—ovarian cancer	0.00093	0.00236	CcSEcCtD
Argatroban—Renal failure acute—Epirubicin—ovarian cancer	0.000921	0.00234	CcSEcCtD
Argatroban—F2—Regulation of IGF Activity by IGFBP—MMP2—ovarian cancer	0.00092	0.0225	CbGpPWpGaD
Argatroban—Hypersensitivity—Melphalan—ovarian cancer	0.000917	0.00233	CcSEcCtD
Argatroban—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000909	0.00231	CcSEcCtD
Argatroban—Vomiting—Chlorambucil—ovarian cancer	0.000908	0.0023	CcSEcCtD
Argatroban—Feeling abnormal—Vinorelbine—ovarian cancer	0.000896	0.00227	CcSEcCtD
Argatroban—Renal impairment—Epirubicin—ovarian cancer	0.000894	0.00227	CcSEcCtD
Argatroban—Dermatitis bullous—Epirubicin—ovarian cancer	0.00089	0.00226	CcSEcCtD
Argatroban—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000889	0.00226	CcSEcCtD
Argatroban—Haemoglobin—Docetaxel—ovarian cancer	0.000877	0.00222	CcSEcCtD
Argatroban—Haemorrhage—Docetaxel—ovarian cancer	0.000872	0.00221	CcSEcCtD
Argatroban—Cardiac failure—Epirubicin—ovarian cancer	0.000871	0.00221	CcSEcCtD
Argatroban—Diarrhoea—Topotecan—ovarian cancer	0.000869	0.00221	CcSEcCtD
Argatroban—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000868	0.0022	CcSEcCtD
Argatroban—Back pain—Paclitaxel—ovarian cancer	0.000867	0.0022	CcSEcCtD
Argatroban—Abdominal pain—Vinorelbine—ovarian cancer	0.000859	0.00218	CcSEcCtD
Argatroban—Body temperature increased—Vinorelbine—ovarian cancer	0.000859	0.00218	CcSEcCtD
Argatroban—Renal failure acute—Doxorubicin—ovarian cancer	0.000852	0.00216	CcSEcCtD
Argatroban—Diarrhoea—Melphalan—ovarian cancer	0.000851	0.00216	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00085	0.00216	CcSEcCtD
Argatroban—Nausea—Chlorambucil—ovarian cancer	0.000848	0.00215	CcSEcCtD
Argatroban—Dizziness—Topotecan—ovarian cancer	0.00084	0.00213	CcSEcCtD
Argatroban—Renal impairment—Doxorubicin—ovarian cancer	0.000827	0.0021	CcSEcCtD
Argatroban—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000823	0.00209	CcSEcCtD
Argatroban—F2—Post-translational protein modification—MUC16—ovarian cancer	0.000811	0.0198	CbGpPWpGaD
Argatroban—Cardiac arrest—Epirubicin—ovarian cancer	0.000809	0.00205	CcSEcCtD
Argatroban—Vomiting—Topotecan—ovarian cancer	0.000808	0.00205	CcSEcCtD
Argatroban—Cardiac failure—Doxorubicin—ovarian cancer	0.000806	0.00205	CcSEcCtD
Argatroban—CYP3A5—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000806	0.0197	CbGpPWpGaD
Argatroban—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000803	0.00204	CcSEcCtD
Argatroban—Rash—Topotecan—ovarian cancer	0.000801	0.00203	CcSEcCtD
Argatroban—Hypersensitivity—Vinorelbine—ovarian cancer	0.000801	0.00203	CcSEcCtD
Argatroban—Dermatitis—Topotecan—ovarian cancer	0.0008	0.00203	CcSEcCtD
Argatroban—Headache—Topotecan—ovarian cancer	0.000796	0.00202	CcSEcCtD
Argatroban—Angiopathy—Docetaxel—ovarian cancer	0.000791	0.00201	CcSEcCtD
Argatroban—Vomiting—Melphalan—ovarian cancer	0.000791	0.00201	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000787	0.002	CcSEcCtD
Argatroban—Rash—Melphalan—ovarian cancer	0.000784	0.00199	CcSEcCtD
Argatroban—Dermatitis—Melphalan—ovarian cancer	0.000784	0.00199	CcSEcCtD
Argatroban—Cough—Paclitaxel—ovarian cancer	0.000782	0.00198	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.000766	0.0188	CbGpPWpGaD
Argatroban—Chest pain—Paclitaxel—ovarian cancer	0.000763	0.00194	CcSEcCtD
Argatroban—Nausea—Topotecan—ovarian cancer	0.000755	0.00192	CcSEcCtD
Argatroban—Cardiac arrest—Doxorubicin—ovarian cancer	0.000748	0.0019	CcSEcCtD
Argatroban—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.000745	0.0182	CbGpPWpGaD
Argatroban—Diarrhoea—Vinorelbine—ovarian cancer	0.000744	0.00189	CcSEcCtD
Argatroban—Nausea—Melphalan—ovarian cancer	0.000739	0.00188	CcSEcCtD
Argatroban—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000738	0.0181	CbGpPWpGaD
Argatroban—Confusional state—Paclitaxel—ovarian cancer	0.000737	0.00187	CcSEcCtD
Argatroban—Back pain—Docetaxel—ovarian cancer	0.000734	0.00186	CcSEcCtD
Argatroban—Infection—Paclitaxel—ovarian cancer	0.000726	0.00184	CcSEcCtD
Argatroban—Dizziness—Vinorelbine—ovarian cancer	0.000719	0.00182	CcSEcCtD
Argatroban—Angina pectoris—Epirubicin—ovarian cancer	0.000716	0.00182	CcSEcCtD
Argatroban—Tachycardia—Paclitaxel—ovarian cancer	0.000714	0.00181	CcSEcCtD
Argatroban—Vomiting—Vinorelbine—ovarian cancer	0.000691	0.00175	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.00069	0.0169	CbGpPWpGaD
Argatroban—Rash—Vinorelbine—ovarian cancer	0.000685	0.00174	CcSEcCtD
Argatroban—Dermatitis—Vinorelbine—ovarian cancer	0.000685	0.00174	CcSEcCtD
Argatroban—Hypotension—Paclitaxel—ovarian cancer	0.000683	0.00173	CcSEcCtD
Argatroban—Headache—Vinorelbine—ovarian cancer	0.000681	0.00173	CcSEcCtD
Argatroban—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000668	0.0163	CbGpPWpGaD
Argatroban—Cough—Docetaxel—ovarian cancer	0.000663	0.00168	CcSEcCtD
Argatroban—Angina pectoris—Doxorubicin—ovarian cancer	0.000662	0.00168	CcSEcCtD
Argatroban—CYP3A5—Irinotecan Pathway—APC—ovarian cancer	0.000662	0.0162	CbGpPWpGaD
Argatroban—Pneumonia—Epirubicin—ovarian cancer	0.000659	0.00167	CcSEcCtD
Argatroban—Dyspnoea—Paclitaxel—ovarian cancer	0.000652	0.00165	CcSEcCtD
Argatroban—Chest pain—Docetaxel—ovarian cancer	0.000646	0.00164	CcSEcCtD
Argatroban—Nausea—Vinorelbine—ovarian cancer	0.000646	0.00164	CcSEcCtD
Argatroban—Dyspepsia—Paclitaxel—ovarian cancer	0.000644	0.00163	CcSEcCtD
Argatroban—Urinary tract infection—Epirubicin—ovarian cancer	0.000637	0.00162	CcSEcCtD
Argatroban—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000631	0.0016	CcSEcCtD
Argatroban—Pain—Paclitaxel—ovarian cancer	0.000625	0.00159	CcSEcCtD
Argatroban—Constipation—Paclitaxel—ovarian cancer	0.000625	0.00159	CcSEcCtD
Argatroban—Haematuria—Epirubicin—ovarian cancer	0.000625	0.00159	CcSEcCtD
Argatroban—Confusional state—Docetaxel—ovarian cancer	0.000625	0.00159	CcSEcCtD
Argatroban—F2—Folate Metabolism—SOD1—ovarian cancer	0.000624	0.0153	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—MMP9—ovarian cancer	0.000621	0.0152	CbGpPWpGaD
Argatroban—Infection—Docetaxel—ovarian cancer	0.000616	0.00156	CcSEcCtD
Argatroban—Pneumonia—Doxorubicin—ovarian cancer	0.00061	0.00155	CcSEcCtD
Argatroban—Tachycardia—Docetaxel—ovarian cancer	0.000605	0.00153	CcSEcCtD
Argatroban—Feeling abnormal—Paclitaxel—ovarian cancer	0.000602	0.00153	CcSEcCtD
Argatroban—Bradycardia—Epirubicin—ovarian cancer	0.000599	0.00152	CcSEcCtD
Argatroban—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000598	0.00152	CcSEcCtD
Argatroban—Haemoglobin—Epirubicin—ovarian cancer	0.000591	0.0015	CcSEcCtD
Argatroban—Urinary tract infection—Doxorubicin—ovarian cancer	0.000589	0.0015	CcSEcCtD
Argatroban—Haemorrhage—Epirubicin—ovarian cancer	0.000588	0.00149	CcSEcCtD
Argatroban—Hypotension—Docetaxel—ovarian cancer	0.000579	0.00147	CcSEcCtD
Argatroban—Haematuria—Doxorubicin—ovarian cancer	0.000578	0.00147	CcSEcCtD
Argatroban—Body temperature increased—Paclitaxel—ovarian cancer	0.000578	0.00147	CcSEcCtD
Argatroban—Abdominal pain—Paclitaxel—ovarian cancer	0.000578	0.00147	CcSEcCtD
Argatroban—F2—Folate Metabolism—SOD2—ovarian cancer	0.000562	0.0137	CbGpPWpGaD
Argatroban—Bradycardia—Doxorubicin—ovarian cancer	0.000554	0.00141	CcSEcCtD
Argatroban—Dyspnoea—Docetaxel—ovarian cancer	0.000552	0.0014	CcSEcCtD
Argatroban—Haemoglobin—Doxorubicin—ovarian cancer	0.000547	0.00139	CcSEcCtD
Argatroban—Dyspepsia—Docetaxel—ovarian cancer	0.000545	0.00138	CcSEcCtD
Argatroban—Haemorrhage—Doxorubicin—ovarian cancer	0.000544	0.00138	CcSEcCtD
Argatroban—Hypersensitivity—Paclitaxel—ovarian cancer	0.000539	0.00137	CcSEcCtD
Argatroban—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000535	0.00136	CcSEcCtD
Argatroban—Angiopathy—Epirubicin—ovarian cancer	0.000534	0.00135	CcSEcCtD
Argatroban—Pain—Docetaxel—ovarian cancer	0.00053	0.00134	CcSEcCtD
Argatroban—Constipation—Docetaxel—ovarian cancer	0.00053	0.00134	CcSEcCtD
Argatroban—Feeling abnormal—Docetaxel—ovarian cancer	0.000511	0.0013	CcSEcCtD
Argatroban—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000507	0.00129	CcSEcCtD
Argatroban—Diarrhoea—Paclitaxel—ovarian cancer	0.0005	0.00127	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—SOD1—ovarian cancer	0.000495	0.0121	CbGpPWpGaD
Argatroban—Back pain—Epirubicin—ovarian cancer	0.000495	0.00126	CcSEcCtD
Argatroban—Angiopathy—Doxorubicin—ovarian cancer	0.000494	0.00125	CcSEcCtD
Argatroban—F2—Syndecan-4-mediated signaling events—MMP9—ovarian cancer	0.000494	0.0121	CbGpPWpGaD
Argatroban—Abdominal pain—Docetaxel—ovarian cancer	0.00049	0.00124	CcSEcCtD
Argatroban—Body temperature increased—Docetaxel—ovarian cancer	0.00049	0.00124	CcSEcCtD
Argatroban—Dizziness—Paclitaxel—ovarian cancer	0.000483	0.00123	CcSEcCtD
Argatroban—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000474	0.0116	CbGpPWpGaD
Argatroban—Vomiting—Paclitaxel—ovarian cancer	0.000465	0.00118	CcSEcCtD
Argatroban—Rash—Paclitaxel—ovarian cancer	0.000461	0.00117	CcSEcCtD
Argatroban—Dermatitis—Paclitaxel—ovarian cancer	0.000461	0.00117	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—ovarian cancer	0.00046	0.0112	CbGpPWpGaD
Argatroban—Back pain—Doxorubicin—ovarian cancer	0.000458	0.00116	CcSEcCtD
Argatroban—Headache—Paclitaxel—ovarian cancer	0.000458	0.00116	CcSEcCtD
Argatroban—Hypersensitivity—Docetaxel—ovarian cancer	0.000457	0.00116	CcSEcCtD
Argatroban—Cough—Epirubicin—ovarian cancer	0.000447	0.00113	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—SOD2—ovarian cancer	0.000446	0.0109	CbGpPWpGaD
Argatroban—Chest pain—Epirubicin—ovarian cancer	0.000436	0.00111	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—PIK3CA—ovarian cancer	0.000436	0.0107	CbGpPWpGaD
Argatroban—Nausea—Paclitaxel—ovarian cancer	0.000434	0.0011	CcSEcCtD
Argatroban—Diarrhoea—Docetaxel—ovarian cancer	0.000424	0.00108	CcSEcCtD
Argatroban—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000424	0.0104	CbGpPWpGaD
Argatroban—Confusional state—Epirubicin—ovarian cancer	0.000421	0.00107	CcSEcCtD
Argatroban—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK3—ovarian cancer	0.000419	0.0103	CbGpPWpGaD
Argatroban—Infection—Epirubicin—ovarian cancer	0.000415	0.00105	CcSEcCtD
Argatroban—Cough—Doxorubicin—ovarian cancer	0.000414	0.00105	CcSEcCtD
Argatroban—Dizziness—Docetaxel—ovarian cancer	0.00041	0.00104	CcSEcCtD
Argatroban—Tachycardia—Epirubicin—ovarian cancer	0.000408	0.00104	CcSEcCtD
Argatroban—Chest pain—Doxorubicin—ovarian cancer	0.000403	0.00102	CcSEcCtD
Argatroban—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—ovarian cancer	0.000399	0.00976	CbGpPWpGaD
Argatroban—Vomiting—Docetaxel—ovarian cancer	0.000394	0.001	CcSEcCtD
Argatroban—Rash—Docetaxel—ovarian cancer	0.000391	0.000991	CcSEcCtD
Argatroban—Hypotension—Epirubicin—ovarian cancer	0.000391	0.000991	CcSEcCtD
Argatroban—Dermatitis—Docetaxel—ovarian cancer	0.00039	0.000991	CcSEcCtD
Argatroban—Confusional state—Doxorubicin—ovarian cancer	0.00039	0.00099	CcSEcCtD
Argatroban—Headache—Docetaxel—ovarian cancer	0.000388	0.000985	CcSEcCtD
Argatroban—F2—Metabolism of proteins—MUC16—ovarian cancer	0.000385	0.00941	CbGpPWpGaD
Argatroban—Infection—Doxorubicin—ovarian cancer	0.000384	0.000975	CcSEcCtD
Argatroban—Tachycardia—Doxorubicin—ovarian cancer	0.000377	0.000958	CcSEcCtD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000375	0.00917	CbGpPWpGaD
Argatroban—Dyspnoea—Epirubicin—ovarian cancer	0.000373	0.000946	CcSEcCtD
Argatroban—Nausea—Docetaxel—ovarian cancer	0.000368	0.000934	CcSEcCtD
Argatroban—Dyspepsia—Epirubicin—ovarian cancer	0.000368	0.000934	CcSEcCtD
Argatroban—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000365	0.00894	CbGpPWpGaD
Argatroban—Hypotension—Doxorubicin—ovarian cancer	0.000361	0.000917	CcSEcCtD
Argatroban—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000361	0.000916	CcSEcCtD
Argatroban—Constipation—Epirubicin—ovarian cancer	0.000357	0.000907	CcSEcCtD
Argatroban—Pain—Epirubicin—ovarian cancer	0.000357	0.000907	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000348	0.00851	CbGpPWpGaD
Argatroban—Dyspnoea—Doxorubicin—ovarian cancer	0.000345	0.000875	CcSEcCtD
Argatroban—Feeling abnormal—Epirubicin—ovarian cancer	0.000344	0.000874	CcSEcCtD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000343	0.0084	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000342	0.000867	CcSEcCtD
Argatroban—Dyspepsia—Doxorubicin—ovarian cancer	0.00034	0.000864	CcSEcCtD
Argatroban—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000334	0.000847	CcSEcCtD
Argatroban—Pain—Doxorubicin—ovarian cancer	0.000331	0.000839	CcSEcCtD
Argatroban—Constipation—Doxorubicin—ovarian cancer	0.000331	0.000839	CcSEcCtD
Argatroban—Abdominal pain—Epirubicin—ovarian cancer	0.00033	0.000838	CcSEcCtD
Argatroban—Body temperature increased—Epirubicin—ovarian cancer	0.00033	0.000838	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—CAV1—ovarian cancer	0.00033	0.00807	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.000326	0.00799	CbGpPWpGaD
Argatroban—Feeling abnormal—Doxorubicin—ovarian cancer	0.000319	0.000809	CcSEcCtD
Argatroban—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000316	0.000803	CcSEcCtD
Argatroban—F2—Hemostasis—RAD51C—ovarian cancer	0.000315	0.00771	CbGpPWpGaD
Argatroban—Hypersensitivity—Epirubicin—ovarian cancer	0.000308	0.000781	CcSEcCtD
Argatroban—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000308	0.00753	CbGpPWpGaD
Argatroban—Body temperature increased—Doxorubicin—ovarian cancer	0.000306	0.000776	CcSEcCtD
Argatroban—Abdominal pain—Doxorubicin—ovarian cancer	0.000306	0.000776	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK3—ovarian cancer	0.000293	0.00718	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL2—ovarian cancer	0.000292	0.00715	CbGpPWpGaD
Argatroban—Diarrhoea—Epirubicin—ovarian cancer	0.000286	0.000726	CcSEcCtD
Argatroban—Hypersensitivity—Doxorubicin—ovarian cancer	0.000285	0.000723	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000282	0.0069	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—ovarian cancer	0.000279	0.00683	CbGpPWpGaD
Argatroban—Dizziness—Epirubicin—ovarian cancer	0.000276	0.000701	CcSEcCtD
Argatroban—F2—PAR1-mediated thrombin signaling events—PIK3CA—ovarian cancer	0.000273	0.00669	CbGpPWpGaD
Argatroban—Vomiting—Epirubicin—ovarian cancer	0.000266	0.000674	CcSEcCtD
Argatroban—Diarrhoea—Doxorubicin—ovarian cancer	0.000265	0.000671	CcSEcCtD
Argatroban—Rash—Epirubicin—ovarian cancer	0.000264	0.000669	CcSEcCtD
Argatroban—Dermatitis—Epirubicin—ovarian cancer	0.000263	0.000668	CcSEcCtD
Argatroban—Headache—Epirubicin—ovarian cancer	0.000262	0.000664	CcSEcCtD
Argatroban—Dizziness—Doxorubicin—ovarian cancer	0.000256	0.000649	CcSEcCtD
Argatroban—F2—Platelet Aggregation (Plug Formation)—AKT1—ovarian cancer	0.000252	0.00616	CbGpPWpGaD
Argatroban—Nausea—Epirubicin—ovarian cancer	0.000248	0.00063	CcSEcCtD
Argatroban—F2—Metabolism of proteins—INHA—ovarian cancer	0.000248	0.00607	CbGpPWpGaD
Argatroban—Vomiting—Doxorubicin—ovarian cancer	0.000246	0.000624	CcSEcCtD
Argatroban—Rash—Doxorubicin—ovarian cancer	0.000244	0.000619	CcSEcCtD
Argatroban—Dermatitis—Doxorubicin—ovarian cancer	0.000244	0.000618	CcSEcCtD
Argatroban—Headache—Doxorubicin—ovarian cancer	0.000242	0.000615	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—ovarian cancer	0.000242	0.00593	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.000237	0.0058	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CB—ovarian cancer	0.00023	0.00563	CbGpPWpGaD
Argatroban—Nausea—Doxorubicin—ovarian cancer	0.00023	0.000583	CcSEcCtD
Argatroban—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00022	0.00539	CbGpPWpGaD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000219	0.00536	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CG—ovarian cancer	0.000217	0.0053	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—APC—ovarian cancer	0.000217	0.0053	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000211	0.00517	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00021	0.00513	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.0002	0.0049	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—ovarian cancer	0.000198	0.00484	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CD—ovarian cancer	0.00019	0.00466	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—ovarian cancer	0.000188	0.00459	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HSD17B6—ovarian cancer	0.000181	0.00444	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—NRAS—ovarian cancer	0.000177	0.00434	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—TUBB3—ovarian cancer	0.000175	0.00427	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL6—ovarian cancer	0.000172	0.0042	CbGpPWpGaD
Argatroban—F2—Hemostasis—SPARC—ovarian cancer	0.000168	0.00412	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	0.000168	0.00411	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CB—ovarian cancer	0.000166	0.00406	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000162	0.00396	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00016	0.00391	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000158	0.00386	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DLC1—ovarian cancer	0.000154	0.00377	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.000153	0.00374	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP1B1—ovarian cancer	0.00015	0.00367	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000148	0.00362	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—ATF3—ovarian cancer	0.000147	0.00361	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.00014	0.00343	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000139	0.0034	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—ovarian cancer	0.000136	0.00334	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.000131	0.00321	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000131	0.00321	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.00013	0.00318	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—NRAS—ovarian cancer	0.000128	0.00313	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BCL9—ovarian cancer	0.000126	0.00307	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK3—ovarian cancer	0.000122	0.003	CbGpPWpGaD
Argatroban—F2—Hemostasis—SOD1—ovarian cancer	0.000122	0.00299	CbGpPWpGaD
Argatroban—F2—Hemostasis—PPP2R1A—ovarian cancer	0.000122	0.00298	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000121	0.00296	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK1—ovarian cancer	0.000117	0.00285	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGFR—ovarian cancer	0.000117	0.00285	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000111	0.00272	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—KRAS—ovarian cancer	0.00011	0.00269	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CA—ovarian cancer	0.000101	0.00247	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DOK1—ovarian cancer	9.93e-05	0.00243	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	9.54e-05	0.00233	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	9.45e-05	0.00231	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PPP1CC—ovarian cancer	9.34e-05	0.00228	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	9.14e-05	0.00224	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NME2—ovarian cancer	9.13e-05	0.00224	CbGpPWpGaD
Argatroban—F2—Hemostasis—CAV1—ovarian cancer	8.94e-05	0.00219	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	8.94e-05	0.00219	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	8.8e-05	0.00215	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	8.69e-05	0.00213	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	8.69e-05	0.00213	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	8.5e-05	0.00208	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—PIK3CA—ovarian cancer	8.43e-05	0.00206	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	8.21e-05	0.00201	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CG—ovarian cancer	8.14e-05	0.00199	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	7.54e-05	0.00185	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	7.38e-05	0.00181	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CD—ovarian cancer	7.16e-05	0.00175	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HDAC6—ovarian cancer	7.08e-05	0.00173	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PPP2R1A—ovarian cancer	6.98e-05	0.00171	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	6.98e-05	0.00171	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.97e-05	0.0017	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.87e-05	0.00168	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—ovarian cancer	6.7e-05	0.00164	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	6.68e-05	0.00163	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—YAP1—ovarian cancer	6.26e-05	0.00153	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CB—ovarian cancer	6.24e-05	0.00153	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—XIAP—ovarian cancer	6.14e-05	0.0015	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	6.03e-05	0.00147	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SMARCA4—ovarian cancer	5.98e-05	0.00146	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYTB—ovarian cancer	5.89e-05	0.00144	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EREG—ovarian cancer	5.84e-05	0.00143	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—ovarian cancer	5.73e-05	0.0014	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP2—ovarian cancer	5.68e-05	0.00139	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PGR—ovarian cancer	5.47e-05	0.00134	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—ovarian cancer	5.15e-05	0.00126	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BRIP1—ovarian cancer	5.14e-05	0.00126	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPP1CC—ovarian cancer	5.14e-05	0.00126	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PARP1—ovarian cancer	5.08e-05	0.00124	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—ovarian cancer	4.87e-05	0.00119	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6ST—ovarian cancer	4.86e-05	0.00119	CbGpPWpGaD
Argatroban—F2—Hemostasis—NRAS—ovarian cancer	4.81e-05	0.00118	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—ovarian cancer	4.72e-05	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—ovarian cancer	4.67e-05	0.00114	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK3—ovarian cancer	4.61e-05	0.00113	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CD—ovarian cancer	4.52e-05	0.00111	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK1—ovarian cancer	4.38e-05	0.00107	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTNNB1—ovarian cancer	4.35e-05	0.00106	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NME2—ovarian cancer	4.25e-05	0.00104	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—ovarian cancer	4.14e-05	0.00101	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PPP2R1A—ovarian cancer	4.12e-05	0.00101	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CD—ovarian cancer	4.11e-05	0.00101	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CB—ovarian cancer	3.94e-05	0.000965	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—ovarian cancer	3.8e-05	0.000931	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—ovarian cancer	3.79e-05	0.000927	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—ovarian cancer	3.68e-05	0.0009	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—ovarian cancer	3.62e-05	0.000886	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CB—ovarian cancer	3.58e-05	0.000876	CbGpPWpGaD
Argatroban—F2—Hemostasis—HRAS—ovarian cancer	3.52e-05	0.000861	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—YAP1—ovarian cancer	3.45e-05	0.000844	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—ovarian cancer	3.44e-05	0.000842	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—ovarian cancer	3.29e-05	0.000805	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TERT—ovarian cancer	3.28e-05	0.000802	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—ovarian cancer	3.11e-05	0.00076	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CAV1—ovarian cancer	3.03e-05	0.000741	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ESR1—ovarian cancer	2.92e-05	0.000715	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6ST—ovarian cancer	2.87e-05	0.000703	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FASN—ovarian cancer	2.81e-05	0.000688	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A5—ovarian cancer	2.77e-05	0.000677	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—ovarian cancer	2.76e-05	0.000675	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APC—ovarian cancer	2.76e-05	0.000675	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—NRAS—ovarian cancer	2.76e-05	0.000675	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYTB—ovarian cancer	2.74e-05	0.00067	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC2A1—ovarian cancer	2.67e-05	0.000654	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK3—ovarian cancer	2.64e-05	0.000647	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1B1—ovarian cancer	2.56e-05	0.000627	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK1—ovarian cancer	2.52e-05	0.000615	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—ovarian cancer	2.51e-05	0.000615	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CD—ovarian cancer	2.43e-05	0.000594	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—ovarian cancer	2.4e-05	0.000588	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.39e-05	0.000585	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.39e-05	0.000585	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—ovarian cancer	2.38e-05	0.000581	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	2.27e-05	0.000556	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—ovarian cancer	2.18e-05	0.000534	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB2—ovarian cancer	2.14e-05	0.000524	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MTOR—ovarian cancer	2.12e-05	0.000518	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CB—ovarian cancer	2.12e-05	0.000518	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCB1—ovarian cancer	2.11e-05	0.000516	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TYMS—ovarian cancer	2.07e-05	0.000507	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—ovarian cancer	2.03e-05	0.000497	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HRAS—ovarian cancer	2.02e-05	0.000494	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1B—ovarian cancer	1.98e-05	0.000486	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—ovarian cancer	1.96e-05	0.00048	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—ovarian cancer	1.95e-05	0.000476	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—ovarian cancer	1.94e-05	0.000475	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—ovarian cancer	1.93e-05	0.000473	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—ovarian cancer	1.89e-05	0.000463	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNB1—ovarian cancer	1.88e-05	0.000459	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—ovarian cancer	1.84e-05	0.00045	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—ovarian cancer	1.83e-05	0.000447	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—ovarian cancer	1.78e-05	0.000436	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAV1—ovarian cancer	1.67e-05	0.000409	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—ovarian cancer	1.65e-05	0.000404	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—ovarian cancer	1.63e-05	0.0004	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NRAS—ovarian cancer	1.63e-05	0.000399	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—YAP1—ovarian cancer	1.6e-05	0.000393	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK3—ovarian cancer	1.56e-05	0.000382	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—ovarian cancer	1.52e-05	0.000372	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—ovarian cancer	1.52e-05	0.000372	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK1—ovarian cancer	1.49e-05	0.000364	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—ovarian cancer	1.49e-05	0.000364	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—ovarian cancer	1.4e-05	0.000343	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CD—ovarian cancer	1.34e-05	0.000327	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FASN—ovarian cancer	1.31e-05	0.00032	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—ovarian cancer	1.29e-05	0.000315	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.29e-05	0.000315	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—ovarian cancer	1.25e-05	0.000305	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.24e-05	0.000304	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRAS—ovarian cancer	1.19e-05	0.000292	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.19e-05	0.000291	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CB—ovarian cancer	1.17e-05	0.000285	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—ovarian cancer	1.14e-05	0.000279	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.06e-05	0.000258	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—ovarian cancer	1.05e-05	0.000258	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—ovarian cancer	1.01e-05	0.000246	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCB1—ovarian cancer	9.81e-06	0.00024	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TYMS—ovarian cancer	9.63e-06	0.000236	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAV1—ovarian cancer	7.76e-06	0.00019	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—ovarian cancer	7.1e-06	0.000174	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—ovarian cancer	7.07e-06	0.000173	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.22e-06	0.000152	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—ovarian cancer	5.8e-06	0.000142	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.42e-06	0.000133	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—ovarian cancer	4.68e-06	0.000115	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.3e-06	8.08e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—ovarian cancer	2.7e-06	6.6e-05	CbGpPWpGaD
